Lexaria Bioscience gets AUD 3.67 million R&D tax credit
Lexaria Bioscience received an AUD 3,666,611.98 Australian R&D tax credit, or USD 2.6 million, tied to its GLP-1 clinical study.
Lexaria Bioscience received an AUD 3,666,611.98 (USD 2.6M) Australian R&D tax credit tied to its GLP-1 clinical study.Key Highlights:Original SEC Filing: Lexaria Bioscience Corp. [ LEXX ] - 8-K - Sep.
01, 2026This is an AI-powered summary.
It may contain inaccuracies.
Consider verifying important i…